Streetbeat News

Products Services

TNXP

Tonix Pharmaceuticals (NASDAQ:TNXP) shares fell 14.61% after a 60% gain, following Q2 results showing a larger-than-expected loss. The company initiated a Phase 2 trial for TNX-1300, a treatment for acute cocaine intoxication, and highlighted progress on its TNX-801 vaccine for mpox and smallpox.

Portfolio Pulse from Henry Khederian

August 20, 2024 | 10:36 pm

EYEN

Eyenovia plans to offer and sell shares of its common stock or pre-funded warrants. The proceeds will be used for commercialization, clinical studies, and general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:12 pm

AADI

Aadi Bioscience announced that its PRECISION1 trial is unlikely to meet the regulatory threshold for accelerated approval and will be halted. The trial's Independent Data Monitoring Committee found it unlikely to exceed the necessary efficacy threshold. Patients benefiting from nab-sirolimus can transition to an expanded access protocol.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:03 pm

NEXT

NextDecade's subsidiary has withdrawn its application at the Federal Energy Regulatory Commission (FERC) for a proposed carbon capture and storage project at the Rio Grande LNG facility.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 9:01 pm

OMCL

Omnicell, Inc. has launched Central Med Automation Service, a subscription-based solution aimed at optimizing centralized medication management for health systems. This service is expected to improve inventory visibility, scalability, and patient safety.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:39 pm

DXCM

LLY

Diabetes-related stocks fell after Eli Lilly's data showed Tirzepatide injections significantly reduce the risk of progressing to type 2 diabetes.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:30 pm

JCTCF

Jewett-Cameron Trading Company Ltd. (NASDAQ:JCTCF) has launched in-store merchandiser displays for their steel framework for wood fences in major home improvement retailers. The displays were trialed successfully and will expand further in Q1 starting September 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:23 pm

MCHP

Microchip Technology detected potentially suspicious activity in its IT systems, leading to disruptions in some manufacturing facilities and business operations. The company is working to contain and remediate the issue.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:21 pm

AZTR

Azitra shares rose following the announcement of the first patient screening in its Phase 1b clinical trial for ATR-12, aimed at treating Netherton syndrome.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:19 pm

N2OFF

N2OFF shares are rising as the company plans to use its subsidiary, Save Foods, patented treatment to extend the shelf life of fruits and vegetables. This initiative aims to monetize emission reductions by maintaining food in the supply chain.

Portfolio Pulse from Benzinga Newsdesk

August 20, 2024 | 8:16 pm